Decision Resources

From WikiCover

Decision Resources produces healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

Decision Resources combines in-depth primary research with textensive claims-based longitudinal patient-level data from PharMetrics to provide insight into physicians' prescribing trends and the factors that drive therapy product choice, from diagnosis through multiple courses of treatment, for a specific disease (osteoporosis, for example).

In another example, announced August 7, 2007, Decision Resources found that Wyeth's Torisel and Roche/Genentech's Avastin will challenge Pfizer's Sutent as the clinical gold standard for the treatment of metastatic renal cell carcinoma.

Website: http://www.decisionresources.com/